Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Two forms of activated BCR/ABL proteins, P210 and P185, that differ in BCR-derived sequences, are associated with Philadelphia chromosome-positive leukemias. One of these diseases is chronic myelogenous leukemia, an indolent disease arising in hematopoietic stem cells that is almost always associate...

Popoln opis

Bibliografske podrobnosti

izdano v:	Mol Cell Biol
Principais autores:	Kelliher, M, Knott, A, McLaughlin, J, Witte, O N, Rosenberg, N
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis 1991
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC361365/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1875948/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.11.9.4710-4716.1991
Oznake:	Označite Brez oznak, prvi označite!